期刊文献+

耐碳青霉烯类抗生素鲍曼不动杆菌中心静脉插管相关性血行感染危险因素分析 被引量:6

下载PDF
导出
摘要 目的了解我院重症医学科(ICU)临床分离的耐碳青霉烯类抗生素鲍曼不动杆菌(CRAb)所致的中心静脉插管相关性血行感染(CLABSI)的流行病学及耐药情况,以及CRAb致CLABSI的危险因素。方法选择2007年7月至2010年6月入住我院ICU的CRAb感染的患者,通过测定其对常用抗菌药物的敏感性,对CRAb的CLABSI患者进行回顾性研究。结果①ICU中CRAb所致的CLABSI的独立危险因素是分离出病原菌前14 d内接受碳青霉烯类抗生素治疗≥7 d(P=0.015,OR=6.112)、中心静脉插管留置时间≥14 d(P=0.023,OR=2.251)、进行外周血和导管标本培养前24 h APACHEⅡ评分≥20(P=0.041,OR=4.213)。②CRAb组菌株对大部分抗菌药物的耐药率大于90%,仅对头孢哌酮-舒巴坦、米诺环素有较高敏感性(耐药率为43.3%)。结论①分离出CRAb前14 d内接受碳青霉烯类抗生素治疗≥7 d、中心静脉插管留置时间≥14 d及进行外周血和导管标本培养前24 h APACHEⅡ评分≥20是ICU中CRAb所致的CLABSI的独立危险因素。②我院ICU临床分离的CRAb的耐药率较高,CRAb仅对头孢哌酮-舒巴坦、米诺环素保持较高敏感性。
出处 《中国老年学杂志》 CAS CSCD 北大核心 2012年第8期1605-1608,共4页 Chinese Journal of Gerontology
  • 相关文献

参考文献9

  • 1Widmer AF. Infection control and prevention strategies in the ICU[J].Intensive Care Medicine,1994.7.doi:10.1007/BF01713976.
  • 2Vallés J,Ferrer R. Bloodstream infection in the ICU[J].Infectious Disease Clinics of North America,2009,(03):557-569.
  • 3Blot SI,Depuydt P,Annemans L. Clinical and economic outcomes in critically ill patients with nosocomial catheter-related bloodstream infections[J].Clinical Infectious Diseases,2005.1591-1598.
  • 4Mugnier PD,Poirel L,Naas T. Worldwide dissemination of the blaOXA-23 carbapenemase gene of A cinetobacter baumannii[J].Emerging Infectious Diseases,2010,(01):35-40.
  • 5王辉,孙宏莉,廖康,陈冬梅,王清涛,王飞燕,陈民钧,朱元珏.北京和广州地区四家医院不动杆菌碳青霉烯酶基因型研究[J].中华检验医学杂志,2005,28(6):636-641. 被引量:121
  • 6Meyer E,Schwab F,Schreren-Boersch B. Critical care[J].Dis Am Mic,2010.113.
  • 7Hsueh PR,Luh KT. Antimicrobial resistance in atreptococcus pneumoniae in Taiwan[J].Emerging Infectious Diseases,2002,(08):827-832.
  • 8Reed CR,Sessler CN,Clauser FL. Central venous catheter infections:concepts and controversies[J].Intensive Care Medicine,1995.177-180.doi:10.1007/BF01726542.
  • 9黄伟,罗运山,周俊峰,张久之,万献尧.ICU内中心静脉导管相关性血行性感染患者的预后危险因素与住院费用分析[J].中国呼吸与危重监护杂志,2010,9(3):239-242. 被引量:21

二级参考文献25

  • 1刘大鹰,谢正福,施焕中,覃雪军,陈强,肖常青.重症监护病房与非重症监护病房中心静脉导管相关感染的对比研究[J].中国呼吸与危重监护杂志,2006,5(3):162-167. 被引量:45
  • 2Valles J, Ferrer R. Bloodstream infection in the ICU. Infect Dis Clin North Am ,2009,23:557-569.
  • 3Digiovine B, Chenoweth C, Watts C, et al. The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive care unit. Am J Respir Crit Care Med, 1999,160:976- 981.
  • 4Warren DK, Quadir WW, Hollenbeak CS, et al. Attributable cost of catheter-associated bloodstream infections among intensive care patients in a nonteaching hospital. Crit Care Med,2006,34:2084- 2089.
  • 5Renaud B, Brun-Buisson C, ICU-Bacteremia Study Group. Outcomes of primary and catheter-related bacteremia. A cohort and casecontrol study in critically ill patients. Am J Respir Crit Care Med, 2001,163 : 1584-1590.
  • 6Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control, 2008,36:309-332.
  • 7Suljagic V, Cobeljic M, Jankovic S, et al. Nosocomial bloodstream infections in ICU and non-ICU patients. Am J Infect Control,2005, 33:333-340.
  • 8Harbarth S, Ferriere K, Hugonnet S, et al. Epidemiology and prognostic determinants of bloodstream infections in surgical intensive care. Arch Surg, 2002,137 : 1353-1359.
  • 9Bernard GR, Vincent JL, Laterre PF, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med, 2001,344 : 699 -709.
  • 10Marrie TJ, Wu L. Factors influencing in-hospital mortality in community-acquired pneumonia:a prospective study of patients not initially admitted to the ICU. Chest,2005,127:1260-1270.

共引文献139

同被引文献93

  • 1赵培革,李艳华,徐俊萍,葛翠云.耐药鲍曼不动杆菌所致老年医院获得性肺炎相关因素[J].中国老年学杂志,2014,34(5):1360-1362. 被引量:11
  • 2王海宾,阎锡新,薛士敏.机械通气患者下呼吸道感染与气路管道的细菌污染关系的研究[J].临床荟萃,2005,20(4):196-199. 被引量:29
  • 3冯加喜,林云,吕冬青.耐亚胺培南鲍氏不动杆菌医院获得性肺部感染危险因素及耐药性分析[J].中华医院感染学杂志,2006,16(12):1416-1418. 被引量:26
  • 4Conrick MI, Foley M, Roche FM,et al. Catheter-related?infection?inIrish intensive care units diagnosed with HELICS criteria : a multi -centre surveillance study [J]. J Hosp Infect ,2013,83(3) :238-243.
  • 5Pongruangporn M, Ajenjo MC, Russo AJ,et al. Patient- and device-specific risk factors for peripherally inserted?central venous catheter-related bloodstream infections [J]. Infect Control Hosp Epidemiol,2013,34(2):184-189.
  • 6Krause R,Valentin T,Salzer H,et al. Which lumen is the source ofcatheter-related bloodstream infection in patients with multi -lumencentral venous catheters? [J], Infection,2013,41 (1) :49-52.
  • 7Boutaric E,Gilardi M,Cecile W,et al. Impact of clinical practiceguidelines on the incidence of bloodstream infections related to pe-ripherally inserted?central venous catheter?in preterm infants [J].Arch Pediatr,2013,20(2) ; 130-136.
  • 8Chopra V,Anand S,Krein SL,et al. Bloodstream infection, venousthrombosis, and peripherally inserted central catheters : reapprais-ing the evidence [J]. Am J Med,2012,125(8) :733-741.
  • 9Marik PE, Flemmer M, Harrison W. The risk of catheter -relatedbloodstream infection with femoral venous catheters as compared tosubclavian and internal jugular venous catheters : a systematic reviewof the literature and meta-analysis [J]. Crit Care Med,2012,40(8):2479-2485.
  • 10Dijkshoorn Lenie,Nemec Alexandr,Seifert Harald.An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nature reviews. Microbiology . 2007

引证文献6

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部